Pacs (PACS) EBITDA (2023 - 2026)

Pacs has disclosed EBITDA across 4 years of filings, most recently posting $120.0 million for Q1 2026.

• EBITDA for Q1 2026 came in at $120.0 million, up 321.59% year-over-year; the trailing twelve-month figure through Mar 2026 was $352.0 million (up 285.34% YoY), and the FY2025 annual result was $309.6 million, up 151.55% from the prior year.
• EBITDA came in at $120.0 million for Q1 2026 at Pacs, up from $94.7 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $120.0 million in Q1 2026 to a low of -$32.1 million in Q2 2024.
• The 4-year median for EBITDA is $37.6 million (2023), against an average of $48.9 million.
• Across the five-year window, EBITDA slumped 251.19% in 2024 and surged 321.59% in 2026, its largest moves.
• Pacs' EBITDA stood at $62.5 million in 2023, then advanced by 15.1% to $72.0 million in 2024, then surged by 31.55% to $94.7 million in 2025, then climbed by 26.77% to $120.0 million in 2026.
• The last three EBITDA figures came in at $120.0 million (Q1 2026), $94.7 million (Q4 2025), and $86.3 million (Q3 2025), per Business Quant data.